Incidence, treatment, and survival patterns for sacral chordoma in the United States, 1974-2011
IntroductionSacral chordomas represent one half of all chordomas, a rare neoplasm of notochordal remnants. Current NCCN guidelines recommend surgical resection with or without adjuvant radiotherapy, or definitive radiation for unresectable cases. Recent advances in radiation for chordomas include c...
Main Authors: | Esther Yu, Paul Koffer, Thomas DiPetrillo, Timothy James Kinsella |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2016.00203/full |
Similar Items
-
Particle therapy for non-small cell lung tumors: where do we stand?A systematic review of the literature
by: Krista eWink, et al.
Published: (2014-10-01) -
Radiotherapy for Mobile Spine and Sacral Chordoma: A Critical Review and Practical Guide from the Spine Tumor Academy
by: Kristin J. Redmond, et al.
Published: (2023-04-01) -
The preliminary results of proton and carbon ion therapy for chordoma and chondrosarcoma of the skull base and cervical spine
by: Xiyin Guan, et al.
Published: (2019-11-01) -
Surgical Treatment of Sacral Chordoma: The Role of Laparoscopy
by: Sergey K. Efetov, et al.
Published: (2020-03-01) -
Sacral chordoma with metastatic dissemination in a child: case report
by: Camile Cremonese Gobbo, et al.
Published: (2022-09-01)